In Norway, the pharmaceuticals,medicinal chemicals, seasonally adjusted index stands at 171.3 currently, a decrease of 9.4 (-5.2%) compared to 2023 Q4.
Pharmaceuticals,medicinal chemicals, seasonally adjusted index in Norway
No matching regions
Data currently not available for this time and region, try a different time period
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Norway
Pharmaceuticals,medicinal chemicals
Norway Pharmaceuticals,medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals,medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 171.3 | 9.4 |
| 2023 Q4 | 180.7 | 6.6 |
| 2023 Q3 | 174.1 | 12.7 |
| 2023 Q2 | 186.8 | 9.8 |
| 2023 Q1 | 196.6 | 8.8 |
| 2022 Q4 | 187.8 | 12.8 |
| 2022 Q3 | 175.0 | 4.2 |
| 2022 Q2 | 170.8 | 16.9 |
| 2022 Q1 | 153.9 | 1.0 |
| 2021 Q4 | 152.9 | 16.2 |
| 2021 Q3 | 169.1 | 7.0 |
| 2021 Q2 | 162.1 | 0.9 |
| 2021 Q1 | 161.2 | 12.1 |
| 2020 Q4 | 149.1 | 3.3 |
| 2020 Q3 | 145.8 | 10.1 |
| 2020 Q2 | 135.7 | 39.2 |
| 2020 Q1 | 174.9 | 0.5 |
| 2019 Q4 | 174.4 | 7.4 |
| 2019 Q3 | 167.0 | 1.4 |
| 2019 Q2 | 168.4 | 12.2 |
| 2019 Q1 | 156.2 | 16.9 |
| 2018 Q4 | 173.1 | 1.3 |
| 2018 Q3 | 174.4 | 5.5 |
| 2018 Q2 | 168.9 | 8.9 |
| 2018 Q1 | 160.0 | 0.3 |
| 2017 Q4 | 160.3 | 1.9 |
| 2017 Q3 | 158.4 | 8.1 |
| 2017 Q2 | 166.5 | 48.7 |
| 2017 Q1 | 215.2 | 40.0 |
| 2016 Q4 | 175.2 | 2.1 |
| 2016 Q3 | 173.1 | 23.1 |
| 2016 Q2 | 150.0 | 33.2 |
| 2016 Q1 | 116.8 | 15.0 |
| 2015 Q4 | 101.8 | 0.2 |
| 2015 Q3 | 101.6 | 3.7 |
| 2015 Q2 | 97.9 | 0.7 |
| 2015 Q1 | 98.6 | 6.2 |
| 2014 Q4 | 92.4 | 1.1 |
| 2014 Q3 | 91.3 | 4.7 |
| 2014 Q2 | 86.6 | 1.2 |
| 2014 Q1 | 87.8 | 1.9 |
| 2013 Q4 | 89.7 | 5.5 |
| 2013 Q3 | 84.2 | 3.6 |
| 2013 Q2 | 87.8 | 0.6 |
| 2013 Q1 | 88.4 | 26.1 |
| 2012 Q4 | 114.5 | 0.9 |
| 2012 Q3 | 113.6 | 2.1 |
| 2012 Q2 | 115.7 | 39.2 |
| 2012 Q1 | 76.5 | 5.1 |
| 2011 Q4 | 81.6 | 1.8 |
| 2011 Q3 | 79.8 | 19.9 |
| 2011 Q2 | 99.7 | 5.8 |
| 2011 Q1 | 105.5 | 15.0 |
| 2010 Q4 | 120.5 | 12.9 |
| 2010 Q3 | 107.6 | 41.3 |
| 2010 Q2 | 66.3 | 9.0 |
| 2010 Q1 | 75.3 | 7.1 |
| 2009 Q4 | 68.2 | 0.5 |
| 2009 Q3 | 68.7 | 1.8 |
| 2009 Q2 | 66.9 | 8.4 |
| 2009 Q1 | 75.3 | 3.7 |
| 2008 Q4 | 79.0 | 3.0 |
| 2008 Q3 | 76.0 | 12.1 |
| 2008 Q2 | 88.1 | 5.2 |
| 2008 Q1 | 82.9 | 2.6 |
| 2007 Q4 | 85.5 | 0.0 |
| 2007 Q3 | 85.5 | 5.5 |
| 2007 Q2 | 91.0 | 13.1 |
| 2007 Q1 | 77.9 | 6.1 |
| 2006 Q4 | 84.0 | 3.8 |
| 2006 Q3 | 80.2 | 8.4 |
| 2006 Q2 | 71.8 | 4.8 |
| 2006 Q1 | 76.6 | 1.0 |
| 2005 Q4 | 77.6 | 3.9 |
| 2005 Q3 | 81.5 | 0.2 |
| 2005 Q2 | 81.3 | 2.1 |
| 2005 Q1 | 79.2 |